Antitumor Response [ortf]
Mice, C57BL [mamm]
Administration [ocac]
Cyclooxygenase II Inhibitor [orch, phsu]
Cyclooxygenase 2 Inhibitors [orch, phsu]
prescribed [hlca]
Severe [qlco]
Arthritis [dsyn]
Currently [tmco]
Study [mnob]
Human [humn]
Chemoprevention [topp]
Trial [resa]
Recently [tmco]
Agent [chvf]
Reports [inpr]
treatment [ftcn]
CARDIOVASCULAR [bdsy]
toxicity [qlco]
Short-term [tmco]
Administration [ocac]
Cyclooxygenase II Inhibitor [orch, phsu]
celecoxib [orch, phsu]
arrested [dsyn]
Adenoma [neop]
Models, Animal [anim]
Including [ftcn]
Mouse, C57BL [mamm]
celecoxib [orch, phsu]
Administration [ocac]
Intestinal Tumors [neop]
mice [mamm]
Initially [tmco]
involuted [qlco]
Then [tmco]
recurred [phpr]
Levels [qlco]
untreated [fndg]
celecoxib [orch, phsu]
treatment [ftcn]
Initially [tmco]
Suppressed [ftcn]
Cyclo-Oxygenase II [aapp, enzy]
Prostaglandin E [bacs, eico]
Levels [qlco]
molecules [sbst]
Reactivated [ftcn]
PGE [bacs, eico]
Growth Factor [aapp, bacs]
Signal Pathways [moft]
Normal Tissue [tisu]
Cyclo-Oxygenase II [aapp, enzy]
Chemoprevention [topp]
Target [ftcn]
Inhibition [menp]
Enzyme [enzy, orch]
Altered [ftcn]
paracrine [phsf]
Enterocyte [cell]
Regulatory Pathway [ftcn]
chronic [tmco]
celecoxib [orch, phsu]
treatment [ftcn]
effects [qlco]
Enhance [acty]
progression [patf]
Events [evnt]
Intestinal [bpoc]
Tumorigenesis [neop]
Contribute [acty]
treatment [ftcn]
toxicity [qlco]
